A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea

Recruiting now

Conditions studied: Progressive Familial Intrahepatic Cholestasis

In brief

This study will collect information from people with Progressive Familial Intrahepatic Cholestasis (PFIC) as they use odevixibat in their daily lives. Odevixibat is a medicine that helps people with PFIC, a type of rare disease that makes their liver not work well and causes itching and yellow skin. Odevixibat was first allowed to be used for PFIC in babies older than 6 months by the European Medicines Agency (EMA) on 16 July 2021 and by the United States Food and Drug Administration (FDA) on 20 July 2021 for itching in babies older than 3 months. Obevixibat was approved by the Ministry of Food and Drug Safety (MFDS) in South Korea on 23 August 2024. This study will collect information to see how well and how safe odevixibat is in the long run for participants in South Korea.

Key facts

Study ID

NCT07185919

Run by

Ipsen

People needed

10

Starts

2025-10-30

Expected to finish

2032-09-30

Last updated by the study team

2026-08-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosed with PFIC (all types) who have been prescribed odevixibat (independently of the decision to enrol the participant in this registry) by their treating physician
• On (or starting) active odevixibat treatment Note: Participants can remain in the registry during odevixibat treatment interruptions

You may not qualify if…

• Currently participating in a clinical trial with odevixibat
• Currently participating in any interventional clinical trial for PFIC
• Have any contraindication to odevixibat as per the approved label in South Korea.

Where it is running

• Pusan National University Yangsan Hospital — Gyeongsang, South Korea (enrolling)
• Severance Hospital, Yonsei University Health System — Seoul, South Korea (enrolling)
• Seoul National University Hospital — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.